ABOS Acumen Pharmaceuticals, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 12, 2026
$2.04
· of 52w range
· above low
· to high
$1.5052w low
$3.6052w high
Market Cap (MRQ)
$148M
P/E
-1.2
EPS
$-2.00
your badges
52W Range
$2–$4
Analyst Rating
STRONG BUY
Price Target
$8
P/E
-1.2
ROE
-129.4%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
ABOS Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$2.04
Market Cap (MRQ)
$148M
P/E
-1.2
EPS
$-2.00
ROE
-129.4%
Debt/Equity (MRQ)
0.3
52W Range
$2–$4
ABOS Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
EPS$-2.002021-12-31 → 2025-12-31
Free Cash Flow$-116M2021-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | ABOS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -1.25Y avg ≈-2.4 | ≈-2.4 | · | · | |
| P/B (MRQ) | 2.65Y avg ≈1.1 | ≈1.1 | 2.5 | Overvalued | |
| EV / EBITDA | -0.3 | · | · | · | |
| Price / FCF (TTM) | -1.65Y avg ≈-5.8 | ≈-5.8 | · | · | |
| Price / Cash Flow (TTM) | -1.65Y avg ≈-5.8 | ≈-5.8 | · | · | |
| EV / FCF (TTM) | -0.6 | · | · | · | |
| Price / Tangible Book | 2.15Y avg ≈1.1 | ≈1.1 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | ABOS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -67.1%5Y avg ≈-43.7% | ≈-43.7% | -56.4% | Weak | |
| ROE | -129.4%5Y avg ≈-53.2% | ≈-53.2% | -60.0% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | ABOS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (MRQ) | 0.3 | · | 0.1 | High debt | |
| Current Ratio (MRQ) | 2.55Y avg ≈13.2 | ≈13.2 | 9.2 | Low liquidity | |
| Quick Ratio | 3.95Y avg ≈8.7 | ≈8.7 | 7.8 | Low liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
2.6%
Next Report
Nov 10, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 12, 2026 | $-0.45 | $-0.37 | -20.2% |
| March 31, 2026 | May 19, 2026 | $-0.33 | $-0.41 | 19.7% |
| Dec. 31, 2025 | $-0.41 | $-0.46 | 11.3% | |
| Sept. 30, 2025 | $-0.44 | $-0.62 | 28.5% | |
| June 30, 2025 | $-0.68 | $-0.55 | -23.9% | |
| March 31, 2025 | $-0.48 | $-0.68 | 29.1% | |
| Dec. 31, 2024 | $-0.62 | $-0.49 | -26.6% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $105M | $94M | $42M | $32M | $12M | $8M | |
| SG&A Expense | $19M | $20M | $19M | $13M | $7M | $1M | |
| Operating Expenses | $124M | $114M | $61M | $45M | $20M | $9M | |
| Operating Income | $-124M | $-114M | $-61M | $-45M | $-20M | $-8M | |
| Interest Expense | · | · | $581.0K | $0 | · | · | |
| Interest Income | $7M | $14M | $11M | $2M | · | · | |
| Other Non-op | $-266.0K | $-151.0K | $-83.0K | $-11.0K | $51.0K | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-121M | $-102M | $-52M | $-43M | $-101M | $-7M | |
| EPS (Basic) | $-2.00 | $-1.71 | $-1.08 | $-1.06 | $-5.02 | · | |
| EPS (Diluted) | $-2.00 | $-1.71 | $-1.08 | $-1.06 | $-5.02 | · | |
| Shares (Basic) | 60,561,836 | 60,013,277 | 48,609,383 | 40,601,936 | 20,057,534 | · | |
| Shares (Diluted) | 60,561,836 | 60,013,277 | 48,609,383 | 40,601,936 | 20,057,534 | · | |
| EBITDA | $-124M | $-114M | $-61M | $-45M | $-20M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $54M | $36M | $67M | $130M | $122M | $44M | |
| Short-term Investments | $63M | $136M | $177M | $48M | $72M | · | |
| Prepaid Expense | $5M | $7M | $3M | $3M | $4M | $543.0K | |
| Other Current Assets | · | · | $283.0K | $237.0K | $140.0K | · | |
| Current Assets | $122M | $178M | $247M | $180M | $199M | $44M | |
| PP&E (Net) | $103.0K | $73.0K | $122.0K | $165.0K | $36.0K | · | |
| Accum. Depreciation | $200.0K | $100.0K | $100.0K | · | · | · | |
| Other Non-current Assets | $350.0K | $486.0K | $724.0K | $151.0K | $14.0K | $0 | |
| Total Assets | $123M | $239M | $310M | $197M | $230M | $44M | |
| Accounts Payable | $554.0K | $6M | $1M | $2M | $1M | $531.0K | |
| Accrued Liabilities | $10M | $7M | $6M | $3M | · | · | |
| Short-term Debt | $9M | $0 | · | · | · | · | |
| Current Liabilities | $30M | $28M | $13M | $8M | $5M | · | |
| Capital Leases | · | $150.0K | $284.0K | $0 | · | · | |
| Other Non-current Liabilities | $0 | $150.0K | $284.0K | · | · | · | |
| Total Liabilities | $52M | $57M | $43M | $8M | $5M | $6M | |
| Long-term Debt | $22M | $29M | $30M | $0 | · | · | |
| Total Debt | $9M | · | · | · | · | · | |
| Common Stock | $6.0K | $6.0K | $6.0K | $4.0K | $4.0K | · | |
| Paid-in Capital | $517M | $507M | $489M | $360M | $353M | $8M | |
| Retained Earnings | $-446M | $-325M | $-223M | $-170M | $-128M | $-27M | |
| AOCI | $83.0K | $-48.0K | $312.0K | $-751.0K | · | · | |
| Stockholders' Equity | $70M | $182M | $267M | $189M | $225M | $-19M | |
| Liabilities + Equity | $123M | $239M | $310M | $197M | $230M | $44M | |
| Shares Outstanding | 60,575,369 | 60,094,083 | 57,910,461 | 41,025,062 | 40,473,270 | 419,124 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $10M | $10M | $6M | $3M | $922.0K | $154.0K | |
| Operating Cash Flow | $-116M | $-86M | $-43M | $-35M | $-18M | $-7M | |
| CapEx | $88.0K | $16.0K | $21.0K | $161.0K | $40.0K | · | |
| Investing Cash Flow | $134M | $48M | $-172M | $39M | $-104M | · | |
| Stock Issued | $0 | $8M | $122M | $4M | $169M | · | |
| Net Stock Activity | $0 | $8M | $122M | $4M | $169M | · | |
| Financing Cash Flow | $-34.0K | $7M | $152M | $4M | $200M | $45M | |
| Taxes Paid | $0 | $0 | $0 | $0 | $0 | $0 | |
| Free Cash Flow | $-116M | $-86M | $-43M | $-35M | $-18M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -67.1% | -37.3% | -20.7% | -20.1% | -73.2% | · | |
| ROE | -129.4% | -51.3% | -19.1% | -22.2% | -43.9% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 4.1 | 6.5 | 19.0 | 23.1 | · | · | |
| Quick Ratio | 3.9 | 6.2 | 18.8 | 6.1 | · | · | |
| Debt / Equity | 0.1 | · | · | · | · | · | |
| Interest Coverage | · | · | -105.2 | · | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.16 | $3.03 | $4.61 | $4.60 | $5.56 | · | |
| Cash Flow / Share | $-1.91 | $-1.44 | $-0.89 | $-0.87 | · | · | |
| Cash / Share | $0.89 | $0.59 | $1.16 | · | $3.02 | · | |
| EPS (TTM) | $-2.00 | $-1.71 | $-1.08 | $-1.06 | $-5.02 | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-121M | $-102M | $-52M | $-43M | $-101M | · | |
| Market Cap | $128M | $103M | $222M | $222M | $274M | · | |
| Enterprise Value | $20M | · | · | · | · | · | |
| P/E | -1.1 | -1.0 | -3.6 | -5.1 | -1.3 | · | |
| P/B | 1.8 | 0.6 | 0.8 | 1.2 | 1.2 | · | |
| P / Tangible Book | 1.8 | 0.6 | 0.8 | 1.2 | 1.2 | · | |
| P / Cash Flow | -1.1 | -1.2 | -5.2 | -6.3 | -15.2 | · | |
| P / FCF | -1.1 | -1.2 | -5.2 | -6.3 | -15.2 | · | |
| EV / EBITDA | -0.2 | · | · | · | · | · | |
| EV / FCF | -0.2 | · | · | · | · | · | |
| Earnings Yield | -94.8% | -99.4% | -28.1% | -19.6% | -74.3% | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $28M | $16M | $21M | $22M | $37M | $25M | $35M | $27M | $20M | $12M | $13M | $11M | $9M | $9M | $11M | $8M | |
| SG&A Expense | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $3M | |
| Operating Expenses | $33M | $21M | $25M | $27M | $42M | $30M | $40M | $32M | $24M | $18M | $18M | $16M | $13M | $13M | $14M | $11M | |
| Operating Income | $-33M | $-21M | $-25M | $-27M | $-42M | $-30M | $-40M | $-32M | $-24M | $-18M | $-18M | $-16M | $-13M | $-13M | $-14M | $-11M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $1M | · | · | · | $0 | · | · | |
| Interest Income | $1M | $1M | $1M | $2M | $2M | $2M | $3M | $4M | $4M | $4M | $4M | $3M | $2M | $2M | · | · | |
| Other Non-op | $-19.0K | $-43.0K | $-4.0K | $-69.0K | $-129.0K | $-64.0K | $-62.0K | $33.0K | $-68.0K | $-54.0K | $-21.0K | $-42.0K | $-16.0K | $-4.0K | $-10.0K | $-2.0K | |
| Net Income | $-33M | $-21M | $-25M | $-26M | $-41M | $-29M | $-37M | $-30M | $-21M | $-15M | $-16M | $-13M | $-12M | $-11M | $-13M | $-11M | |
| EPS (Basic) | $-0.45 | $-0.33 | $-0.40 | $-0.44 | $-0.68 | $-0.48 | $-0.62 | $-0.50 | $-0.34 | $-0.25 | $-0.28 | $-0.24 | $-0.28 | $-0.28 | $-0.32 | $-0.26 | |
| EPS (Diluted) | $-0.45 | $-0.33 | $-0.40 | $-0.44 | $-0.68 | $-0.48 | $-0.62 | $-0.50 | $-0.34 | $-0.25 | $-0.28 | $-0.24 | $-0.28 | $-0.28 | $-0.32 | $-0.26 | |
| Shares (Basic) | 72,250,694 | 63,219,289 | · | 60,573,425 | 60,573,425 | 60,525,628 | · | 60,079,778 | 60,079,778 | 59,812,000 | · | 54,229,630 | 41,025,062 | 41,025,062 | · | 40,502,860 | |
| Shares (Diluted) | 72,250,694 | 63,219,289 | · | 60,573,425 | 60,573,425 | 60,525,628 | · | 60,079,778 | 60,079,778 | 59,812,000 | · | 54,229,630 | 41,025,062 | 41,025,062 | · | 40,502,860 | |
| EBITDA | $-33M | $-21M | · | $-27M | $-42M | $-30M | · | $-32M | $-24M | $-18M | · | $-16M | $-13M | $-13M | · | $-11M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $59M | $52M | $54M | $47M | $37M | $30M | $36M | $33M | $68M | $47M | $67M | $95M | · | · | $130M | $158M | |
| Short-term Investments | $51M | $77M | $63M | $80M | $107M | $119M | $136M | $167M | $193M | $206M | $177M | $121M | $68M | $62M | $48M | $43M | |
| Prepaid Expense | $5M | $5M | $5M | $6M | $5M | $6M | $7M | $7M | $6M | $3M | $3M | $3M | $5M | $4M | $3M | $2M | |
| Other Current Assets | · | · | · | · | · | · | · | $457.0K | $405.0K | $395.0K | · | $181.0K | $208.0K | $294.0K | $237.0K | · | |
| Current Assets | $116M | $133M | $122M | $132M | $148M | $155M | $178M | $208M | $267M | $256M | $247M | $219M | $150M | $144M | $180M | $203M | |
| PP&E (Net) | $80.0K | $91.0K | $103.0K | $115.0K | $130.0K | $137.0K | $73.0K | $89.0K | $105.0K | $117.0K | $122.0K | $123.0K | $136.0K | $151.0K | · | $142.0K | |
| Accum. Depreciation | $100.0K | $200.0K | $200.0K | $100.0K | $100.0K | $100.0K | $100.0K | · | · | · | $100.0K | · | · | · | · | · | |
| Other Non-current Assets | $263.0K | $304.0K | $350.0K | $393.0K | $464.0K | $504.0K | $486.0K | $170.0K | $425.0K | $324.0K | $724.0K | $189.0K | $208.0K | $195.0K | $151.0K | $92.0K | |
| Total Assets | $116M | $134M | $123M | $142M | $172M | $204M | $239M | $267M | $289M | $301M | $310M | $286M | $177M | $188M | $197M | $203M | |
| Accounts Payable | $13M | $2M | $554.0K | $682.0K | $2M | $1M | $6M | $2M | $4M | $3M | $1M | $1M | $2M | $762.0K | $2M | $2M | |
| Accrued Liabilities | $8M | $5M | $10M | $8M | $12M | $7M | $7M | $5M | $4M | $3M | $6M | $3M | $2M | · | $3M | · | |
| Short-term Debt | $20M | $14M | $9M | $4M | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $47M | $29M | $30M | $22M | $25M | $19M | $28M | $20M | $15M | $8M | $13M | $6M | $9M | $9M | $8M | $7M | |
| Capital Leases | · | · | · | $39.0K | $77.0K | $114.0K | $150.0K | $185.0K | $219.0K | $252.0K | $284.0K | · | · | · | $0 | · | |
| Other Non-current Liabilities | · | · | $0 | $39.0K | $77.0K | $114.0K | $150.0K | · | · | · | $284.0K | · | · | · | · | · | |
| Total Liabilities | $59M | $46M | $52M | $49M | $55M | $49M | $57M | $50M | $45M | $39M | $43M | $6M | $9M | $9M | $8M | $7M | |
| Long-term Debt | $12M | $17M | $22M | $27M | $30M | $30M | $29M | $30M | $29M | $30M | $30M | · | · | · | $0 | · | |
| Total Debt | $20M | $14M | · | $4M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $7.0K | $7.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $4.0K | $4.0K | $4.0K | $4.0K | |
| Paid-in Capital | $557M | $555M | $517M | $514M | $512M | $509M | $507M | $505M | $502M | $500M | $489M | $487M | $363M | $361M | $360M | $355M | |
| Retained Earnings | $-500M | $-467M | $-446M | $-421M | $-395M | $-354M | $-325M | $-288M | $-258M | $-238M | $-223M | $-206M | $-193M | $-182M | $-170M | $-158M | |
| AOCI | $-13.0K | $21.0K | $83.0K | $109.0K | $23.0K | $15.0K | $-48.0K | $518.0K | $-164.0K | $-144.0K | $312.0K | $-509.0K | $-646.0K | · | $-751.0K | · | |
| Stockholders' Equity | $57M | $87M | $70M | $93M | $117M | $156M | $182M | $217M | $244M | $262M | $267M | $280M | $169M | $179M | $189M | $197M | |
| Liabilities + Equity | $116M | $134M | $123M | $142M | $172M | $204M | $239M | $267M | $289M | $301M | $310M | $286M | $177M | $188M | $197M | $203M | |
| Shares Outstanding | 72,314,714 | 72,227,580 | 60,575,369 | 60,573,425 | 60,573,425 | 60,573,425 | 60,094,083 | 60,079,778 | 60,079,778 | 60,079,778 | 57,910,461 | 57,910,461 | 41,025,062 | 41,025,062 | 41,025,062 | 40,503,124 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $888.0K | $840.0K | |
| Operating Cash Flow | $-18M | $-24M | $-19M | $-30M | $-32M | $-34M | $-27M | $-25M | $-17M | $-18M | $-8M | $-13M | $-12M | $-10M | $-11M | $-9M | |
| CapEx | $0 | $0 | $0 | $0 | $9.0K | $79.0K | $0 | $0 | $5.0K | $11.0K | $14.0K | $7.0K | $0 | $0 | $35.0K | $81.0K | |
| Investing Cash Flow | $26M | $-14M | $26M | $41M | $38M | $29M | $30M | $-10M | $38M | $-9M | $-49M | $-92M | $11M | $-42M | $-20M | $56M | |
| Stock Issued | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $8M | $-390.0K | $122M | $0 | $0 | $4M | · | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $8M | · | · | · | · | · | · | |
| Financing Cash Flow | $-278.0K | $36M | $2.0K | $0 | $0 | $-36.0K | $-9.0K | $-42.0K | $-128.0K | $7M | $29M | $123M | $-145.0K | $0 | $4M | $-263.0K | |
| Taxes Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | |
| Free Cash Flow | · | $-24M | · | · | · | $-34M | · | · | · | $-18M | · | · | · | $-10M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -22.7% | -12.3% | · | -12.9% | -17.8% | -11.4% | · | -10.8% | -8.8% | -6.1% | · | -5.3% | -6.0% | -5.5% | · | -4.9% | |
| ROE | -37.5% | -17.1% | · | -17.0% | -22.7% | -13.8% | · | -12.0% | -10.0% | -6.7% | · | -5.4% | -6.2% | -5.7% | · | -5.0% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.5 | 4.6 | · | 6.0 | 6.0 | 8.0 | · | 10.4 | 17.4 | 30.2 | · | 35.8 | 17.5 | 16.4 | · | 30.6 | |
| Quick Ratio | 2.4 | 4.4 | · | 5.8 | 5.8 | 7.7 | · | 10.1 | 17.0 | 29.8 | · | 35.3 | 7.9 | 7.1 | · | 30.3 | |
| Debt / Equity | 0.3 | 0.2 | · | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -17.8 | · | · | · | · | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.79 | $1.21 | · | $1.54 | $1.93 | $2.57 | · | $3.62 | $4.06 | $4.36 | · | $4.84 | $4.12 | $4.37 | · | $4.86 | |
| Cash Flow / Share | · | $-0.38 | · | · | · | $-0.56 | · | · | · | $-0.30 | · | · | · | $-0.25 | · | · | |
| Cash / Share | $0.82 | $0.72 | · | $0.77 | $0.61 | $0.50 | · | $0.55 | $1.13 | $0.78 | · | $1.64 | · | · | · | $3.89 | |
| EPS (TTM) | $-1.62 | $-1.85 | · | $-2.22 | $-2.28 | $-1.94 | · | $-1.37 | $-1.11 | $-1.05 | · | $-1.12 | $-1.14 | $-1.11 | · | $1.24 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-105M | $-113M | · | $-133M | $-137M | $-116M | · | $-82M | $-65M | $-56M | · | $-49M | $-46M | $-45M | · | $-38M | |
| Market Cap | $193M | $170M | · | $104M | $70M | $67M | · | $149M | $145M | $243M | · | $240M | $197M | $167M | · | $406M | |
| Enterprise Value | $103M | $56M | · | $-19M | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -1.6 | -1.3 | · | -0.8 | -0.5 | -0.6 | · | -1.8 | -2.2 | -3.9 | · | -3.7 | -4.2 | -3.7 | · | 8.1 | |
| P/B | 3.4 | 1.9 | · | 1.1 | 0.6 | 0.4 | · | 0.7 | 0.6 | 0.9 | · | 0.9 | 1.2 | 0.9 | · | 2.1 | |
| P / Tangible Book | 3.4 | 1.9 | · | 1.1 | 0.6 | 0.4 | · | 0.7 | 0.6 | 0.9 | · | 0.9 | 1.2 | 0.9 | · | 2.1 | |
| P / Cash Flow | · | -7.1 | · | · | · | -2.0 | · | · | · | -13.6 | · | · | · | -16.4 | · | · | |
| Earnings Yield | -60.7% | -78.4% | · | -129.8% | -196.6% | -176.4% | · | -55.2% | -45.9% | -25.9% | · | -27.0% | -23.7% | -27.3% | · | 12.4% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Net Income | $-121M | $-102M | $-52M | $-43M | $-101M |
| Diluted EPS | $-2.00 | $-1.71 | $-1.08 | $-1.06 | $-5.02 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debt / Equity | 0.1 | · | · | · | · |
| Current Ratio | 4.1 | 6.5 | 19.0 | 23.1 | · |
| Quick Ratio | 3.9 | 6.2 | 18.8 | 6.1 | · |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-116M | $-86M | $-43M | $-35M | $-18M |
Institutional owners (13F) 102 filers · $131.5M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
102
Value held
$131.5M
New positions
30
Exited positions
17
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 30 (+4 vs prior Q) | 17 (+12 vs prior Q) | 22 (-9 vs prior Q) | 15 (+3 vs prior Q) | +1.7M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $56,050,426 | 20,992,669 | 42.62% | Shares |
| Sands Capital Alternatives, LLC | $9,932,680 | 3,720,105 | 7.55% | Shares |
| BlackRock, Inc. | $6,648,607 | 2,490,115 | 5.05% | Shares |
| Alyeska Investment Group, L.P. | $6,554,193 | 2,454,754 | 4.98% | Shares |
| FRANKLIN RESOURCES INC | $6,154,606 | 2,305,096 | 4.68% | Shares |
| ADAR1 Capital Management, LLC | $5,637,262 | 2,111,334 | 4.29% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $4,464,432 | 1,672,072 | 3.39% | Shares |
| Knollwood Investment Advisory, LLC | $4,348,122 | 1,628,510 | 3.31% | Shares |
| VANGUARD GROUP INC | $3,489,459 | 1,653,772 | 2.65% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $3,049,286 | 1,141,858 | 2.32% | Shares |
| Ikarian Capital, LLC | $2,813,638 | 1,053,797 | 2.14% | Shares |
| Hudson Bay Capital Management LP | $2,549,850 | 955,000 | 1.94% | Shares |
| Pathstone Holdings, LLC | $2,293,824 | 859,110 | 1.74% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $1,802,317 | 675,025 | 1.37% | Shares |
| TWO SIGMA INVESTMENTS, LP | $1,663,095 | 622,882 | 1.26% | Shares |
| STATE STREET CORP | $1,603,410 | 600,528 | 1.22% | Shares |
| NORTHERN TRUST CORP | $963,187 | 360,744 | 0.73% | Shares |
| TWO SIGMA ADVISERS, LP | $889,998 | 421,800 | 0.68% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $856,523 | 320,795 | 0.65% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $778,969 | 291,559 | 0.59% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $777,611 | 291,240 | 0.59% | Shares |
| BANK OF AMERICA CORP /DE/ | $733,665 | 274,781 | 0.56% | Shares |
| BOOTHBAY FUND MANAGEMENT, LLC | $728,942 | 273,012 | 0.55% | Shares |
| NOMURA HOLDINGS INC | $506,531 | 189,712 | 0.39% | Shares |
| GOLDMAN SACHS GROUP INC | $491,085 | 183,927 | 0.37% | Shares |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $470,377 | 176,171 | 0.36% | Shares |
| MORGAN STANLEY | $365,157 | 136,763 | 0.28% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $336,698 | 126,104 | 0.26% | Shares |
| Bank of New York Mellon Corp | $332,086 | 124,377 | 0.25% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $307,314 | 115,099 | 0.23% | Shares |
| PFG Investments, LLC | $251,648 | 94,250 | 0.19% | Shares |
| CATALYST FINANCIAL PARTNERS LLC | $239,496 | 89,699 | 0.18% | Shares |
| Nuveen, LLC | $169,158 | 63,355 | 0.13% | Shares |
| MILLENNIUM MANAGEMENT LLC | $161,797 | 60,598 | 0.12% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $158,598 | 59,400 | 0.12% | Call option |
| Squarepoint Ops LLC | $139,777 | 52,351 | 0.11% | Shares |
| CITADEL ADVISORS LLC | $136,301 | 51,049 | 0.10% | Shares |
| Prospera Financial Services Inc | $133,500 | 50,000 | 0.10% | Shares |
| WELLS FARGO & COMPANY/MN | $132,661 | 49,686 | 0.10% | Shares |
| MARSHALL WACE, LLP | $128,465 | 48,114 | 0.10% | Shares |
| DEUTSCHE BANK AG\ | $123,172 | 46,132 | 0.09% | Shares |
| Verdad Advisers, LP | $118,756 | 44,478 | 0.09% | Shares |
| BARCLAYS PLC | $105,878 | 39,655 | 0.08% | Shares |
| Qube Research & Technologies Ltd | $103,099 | 38,614 | 0.08% | Shares |
| NEW YORK STATE COMMON RETIREMENT FUND | $96,654 | 36,200 | 0.07% | Shares |
| RHUMBLINE ADVISERS | $93,535 | 35,034 | 0.07% | Shares |
| Rangeley Capital, LLC | $93,450 | 35,000 | 0.07% | Shares |
| XTX Topco Ltd | $85,798 | 32,134 | 0.07% | Shares |
| Intrepid Financial Planning Group LLC | $80,501 | 30,150 | 0.06% | Shares |
| Y-Intercept (Hong Kong) Ltd | $78,872 | 29,540 | 0.06% | Shares |
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×5 filings | March 17, 2026 | 29.50% | Amendment | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 17 insiders · 7 officers · 9 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Daniel Joseph Oconnell | Chief Executive Officer | Jan. 22, 2026 S | 881,275 | 0 | 8 | $-163,230 |
| Matt Zuga | CFO & Chief Business Officer | Jan. 22, 2026 S | 304,924 | 0 | 7 | $-49,630 |
| James J. Doherty | President and CDO | Jan. 16, 2026 A | 220,900 | 0 | 2 | $-15,153 |
| Russell Barton | Chief Operating Officer | Jan. 22, 2026 S | 205,092 | 0 | 6 | $-29,956 |
| Derek M Meisner | Chief Legal Officer & Corp Sec | March 6, 2026 M | 173,999 | 0 | 16 | $-248,780 |
| Eric Siemers | Chief Medical Officer | Jan. 22, 2026 S | 255,371 | 0 | 4 | $-27,128 |
| Amy Schacterle | Chief Regulatory Officer | Jan. 16, 2026 A | 92,303 | 0 | 1 | $-2,172 |
| Derrell Porter | Director | June 17, 2026 M | 35,500 | 0 | 3 | $-75,388 |
| Nathan B Fountain | Director | June 9, 2026 S | 48,150 | 0 | 1 | $-14,272 |
| Laura Stoppel | Director | June 3, 2026 A | 48,300 | 0 | 0 | $0 |
| John A Stalfort III | Director | June 3, 2026 A | 220,624 | 0 | 0 | $0 |
| Jeffrey L. Ives | Director | June 3, 2026 A | 48,300 | 0 | 0 | $0 |
| George Golumbeski | Director | June 3, 2026 A | 35,500 | 0 | 0 | $0 |
| Kimberlee C Drapkin | Director | June 3, 2026 A | 48,300 | 0 | 0 | $0 |
| Jeffrey Sevigny | Director | June 15, 2022 A | · | 0 | 0 | $0 |
| Robert D. Hardie | 10% owner | July 6, 2021 C | 657,985 | 0 | 0 | $0 |
| Paul B Manning | 10% owner | July 6, 2021 C | 657,985 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 14 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IBRN · iShares Trust | 0.19% | 5,024 SH | Sept. 11, 2026 | Daily |
| IWC · iShares Trust | 0.03% | 157,585 SH | Sept. 11, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.01% | 41,102 SH | Aug. 19, 2026 | Daily |
| IWM · iShares Trust | 0.00% | 1,017,131 SH | Sept. 11, 2026 | Daily |
| RSSL · Global X Funds | 0.00% | 22,560 NS | July 31, 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.00% | 4,079 NS | July 31, 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.00% | 100,013 NS | July 31, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 7,149 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 513,511 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1,118,322 SH | Aug. 19, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.00% | 273,215 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 6,478 SH | Aug. 19, 2026 | Daily |
| DFAC · Dimensional ETF Trust | 0.00% | 9,637 NS | July 31, 2026 | N-PORT |
| IWN · iShares Trust | · | 427,467 SH | Sept. 11, 2026 | Daily |
ABOS Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 12 analysts
BUY
Median target
$8.00
+292.2%
6 50.0%
Strong Buy
5 41.7%
Buy
1 8.3%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
5 analysts · 2026-10-02Mean target $7.60 +272.5%
← Below all targets
Current price $2.04
Low$5.00
Mean$7.60
High$10.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| ABOS | $128M | -1.1 | · | · | -129.4% | · |
| TNXP | $200M | -1.1 | 29.8% | -946.2% | -60.0% | · |
| NERV | $174M | -0.1 | · | · | 339.5% | · |
| PEPG | $448M | -3.1 | · | · | -82.0% | · |
| NBP | $1.06B | -19.0 | · | · | -21.4% | · |
| FHTX | $306M | -4.6 | 36.8% | -240.3% | 80.2% | · |
| HUMA | · | · | · | · | · | · |
| OTLK | $57M | -0.6 | · | -4416.2% | 193.1% | 4.0% |
| KRRO | $75M | -0.6 | 181.5% | -1834.5% | -140.8% | · |
| RNA | $10.91B | -14.5 | 72.1% | -3650.4% | -47.5% | · |
| SPRB | $120M | -1.7 | -51.3% | · | -139.9% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 12, 2026